Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Abbott Laboratories : Trump Tests Negative for Covid-19 on Consecutive Days, White House Physician Says -- Update

10/12/2020 | 04:22pm EDT

By Alex Leary

President Trump tested negative for Covid-19 on consecutive days, White House physician Sean Conley said in a memo released Monday afternoon as Mr. Trump traveled to Florida for his first formal campaign rally since being treated for the virus.

Dr. Conley said tests and other measurements "have informed our medical team's assessment that the president is not infectious to others."

The memo didn't specify when Mr. Trump was tested.

Mr. Trump was tested using Abbott Laboratories's BinaxNOW Covid-19 Ag Card, the memo said. The U.S. Food and Drug Administration has granted emergency-use authorization to Abbott Laboratories for a $5 rapid-response Covid-19 antigen test that is roughly the size of a credit card.

"It is important to note that this test was not used in isolation for the determination of the president's current negative status," the doctor's memo said, adding that other data were used. "This comprehensive data, in concert with the CDC's guidelines for removal of transmission-based precautions," informed the team's assessment, the memo said.

The White House has faced pressure to say more about Mr. Trump's testing, and it has declined to say when the president last tested negative before disclosing his positive result around 1 a.m. on Oct. 2, only days after his first debate with Democratic presidential nominee Joe Biden.

Write to Alex Leary at alex.leary@wsj.com

(END) Dow Jones Newswires

10-12-20 1822ET

All news about ABBOTT LABORATORIES
06/21U.S. Supreme Court rebuffs AbbVie appeal in patent fight involving AndroGel d..
RE
06/11INSIDER TRENDS : Insider at Abbott Laboratories Tax Sale Continues 90-Day Sellin..
MT
06/11ABBOTT LABORATORIESá : Maintains Quarterly Dividend of $0.45 Per Share, Payable ..
MT
06/11ABBOTTá : Declares 390th Consecutive Quarterly Dividend
PR
06/07INSIDER TRENDS : Abbott Laboratories Insider Sale for Taxes Adds to 90-Day Selli..
MT
06/07INSIDER TRENDS : Insider at Abbott Laboratories Makes Tax Sale Extends 90-Day Se..
MT
06/07ABBOTT LABORATORIESá : and Walgreens Launch Pilot Program to Increase Access to ..
PU
06/04S&P 500 Posts 0.6% Weekly Increase as May Jobs Climb But Miss Expectations; E..
MT
06/04ABBOTT LABORATORIESá : Confirms capacity to support expanded use of heartmate 3 ..
AQ
06/03Abbott Labs Plans Restructuring Due to Changes in Covid-19 Testing Demand
DJ
More news
Financials (USD)
Sales 2021 39 425 M - -
Net income 2021 5 861 M - -
Net Debt 2021 9 307 M - -
P/E ratio 2021 33,9x
Yield 2021 1,53%
Capitalization 197 B 197 B -
EV / Sales 2021 5,24x
EV / Sales 2022 5,16x
Nbr of Employees 109 000
Free-Float 89,0%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | MarketScreener
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 110,96 $
Average target price 124,86 $
Spread / Average Target 12,5%
EPS Revisions
Managers and Directors
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Robert Emmett Funck Chief Financial Officer & Executive Vice President
Miles D. White Executive Chairman
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Roxanne Schuh Austin Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES1.34%198 009
MEDTRONIC PLC7.17%168 902
BECTON, DICKINSON AND COMPANY-3.75%70 038
ALIGN TECHNOLOGY, INC.14.44%48 395
HOYA CORPORATION1.26%48 348
SARTORIUS STEDIM BIOTECH28.88%41 214